SCIENCE-BACKED RESEARCH

Sick and tired of acid reflux? Even more tired of unsupportive or vague claims of product effectiveness? We’re here to empower you and your research. Read science-backed research papers supporting safety claims for long-term use and pregnancies.

Pregnancy Safe

Review Of Recent Evidence On The Management Of Heartburn In Pregnant And Breastfeeding Women

Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy

Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents

Potential risk of proton-pump inhibitors long-term use

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

Long-term proton pump inhibitor therapy and risk of hip fracture

Do Proton Pump Inhibitors Increase the Risk of Dementia?

The Appropriate Use Of Proton-Pump Inhibitors

What Is The Long-Term Acid Inhibitor Treatment In Gastroesophageal Reflux Disease? What Are The Potential Problems Related To Long Term Acid Inhibitor Treatment In Gastroesophageal Reflux Disease? How Should These Cases Be Followed?

Alginate: How & why it works efficiently

Alginate Therapy Is Effective Treatment For GERD Symptoms: A Systematic Review And Meta-Analysis

Alginates: From The Ocean To Gastroesophageal Reflux Disease Treatment

An Alginate-Antacid Formulation Localizes To The Acid Pocket To Reduce Acid Reflux In Patients With Gastroesophageal Reflux Disease

The Suppression Of Gastro-Oesophageal Reflux By Alginates

Alginate Rafts And Their Characterisation

Randomised Clinical Trial: Alginate (Gaviscon Advance) Vs. Placebo As Add-On Therapy In Reflux Patients With Inadequate Response To A Once Daily Proton Pump Inhibitor

Review Article: Alginate-Raft Formulations In The Treatment Of Heartburn And Acid Reflux

An Alginate-Antacid Formulation (Gaviscon Double Action Liquid®) Can Eliminate The Postprandial “Acid Pocket” In Symptomatic GERD Patients